Generation of CART cells targeting oncogenic TROP2 for the elimination of epithelial malignancies

癌症研究 前列腺 血管生成 癌症 医学 内科学
作者
Darel Martínez Bedoya,T D King,Avery D. Posey
出处
期刊:Cytotherapy [Elsevier BV]
卷期号:21 (5): S11-S12 被引量:11
标识
DOI:10.1016/j.jcyt.2019.03.570
摘要

Background & Aim

TROP2 (also referred to as Tacstd2) is a membrane-associated glycoprotein highly expressed in many epithelial cancers, including oral, head-and-neck, thyroid, lung, esophageal, gastric, colorectal, pancreatic, breast, renal, uterine, cervical, ovarian, prostate, and glioma, and expression of TROP2 negatively correlates with prognosis and survival in many of these malignancies. TROP2 signaling supports tumor growth and progression through the induction of pathways controlling cell cycle progression, invasion and metastasis, proliferation, angiogenesis, cell growth and survival. In addition, tumor release of TROP2-containing exosomes can promote the migration of TROP2-negative tumor cells. Here, we generated several TROP-2-targeting CAR molecules and evaluated their activity as CART cells against various epithelial tumor cell lines.

Methods, Results & Conclusion

Single-chain variable fragments targeting TROP2 were produced through domain sequencing of hybridomas and through other publically available sources and cloned into lentiviral transfer plasmids containing second-generation CAR backbones. Transduction of human T cells routinely leads to the expression of >50% CAR+ cells, including the generation of TROP2-CART cells from T cells of a mTNBC patient. We evaluated interferon-gamma production as well as cytotoxicity of TROP2-CART cells cultured with TROP2+ breast, prostate and pancreatic tumor cells to choose a lead TROP2-CAR. In addition, we generated an isogenic TROP2- prostate cancer through Cas9-based gene editing and observed loss of cytotoxicity, demonstrating specificity of the TROP2-CART. However, TROP2-CART can kill TROP2- cells in the presence of TROP2+ cells, a feature also observed by CART19 when cultured with CD19+ and CD19- cells, consistent prior reports that activated CART cells induce tumor apoptosis through death receptors. Prior reports demonstrated that blockade of death receptor ligands abolished the non-specific cytotoxicity of CART19 cells, but this approach provided only partial blockade of TROP2-CART cytotoxicity. Instead, we describe and demonstrate a new mechanism by which transfer of TROP2+ tumor exosomes to TROP2- tumor cells increases the proportion of tumor targetable by TROP2-CART and may allow TROP2-CART to overcome the challenge of antigen heterogeneity in solid tumors.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
hmwu_test发布了新的文献求助10
1秒前
Shandongdaxiu发布了新的文献求助10
1秒前
刘城发布了新的文献求助10
1秒前
llzuo发布了新的文献求助10
2秒前
3秒前
3秒前
追寻紫安完成签到,获得积分10
4秒前
迷人的天抒应助qweasdzxcqwe采纳,获得10
4秒前
bkagyin应助qweasdzxcqwe采纳,获得10
5秒前
壮观复天完成签到 ,获得积分10
5秒前
5秒前
dalong完成签到,获得积分10
5秒前
开朗的踏歌完成签到,获得积分10
5秒前
5秒前
xxxxxx完成签到,获得积分10
5秒前
xiaoxiao发布了新的文献求助10
7秒前
一只蓉馍馍完成签到,获得积分10
8秒前
的地方法规完成签到,获得积分10
9秒前
9秒前
咖啡的腿毛完成签到 ,获得积分10
10秒前
快乐小白菜完成签到,获得积分10
10秒前
面包发布了新的文献求助10
10秒前
Allen完成签到,获得积分10
11秒前
TranYan完成签到,获得积分10
11秒前
涣醒完成签到,获得积分10
11秒前
zyz完成签到,获得积分10
11秒前
含蓄的孤丝完成签到,获得积分10
12秒前
da完成签到,获得积分10
12秒前
桐桐应助飞翔的秋秋采纳,获得30
12秒前
Levi完成签到,获得积分10
13秒前
迅速天空完成签到 ,获得积分10
13秒前
壹yi完成签到,获得积分10
14秒前
封从霜完成签到,获得积分10
14秒前
milan001完成签到,获得积分10
14秒前
高级的百香果完成签到,获得积分10
14秒前
rong完成签到,获得积分10
14秒前
陈肖楠完成签到,获得积分10
15秒前
OpangziO完成签到,获得积分10
15秒前
小巧弘文完成签到 ,获得积分20
15秒前
guishouyu完成签到 ,获得积分10
15秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 600
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3968637
求助须知:如何正确求助?哪些是违规求助? 3513552
关于积分的说明 11168493
捐赠科研通 3248935
什么是DOI,文献DOI怎么找? 1794554
邀请新用户注册赠送积分活动 875188
科研通“疑难数据库(出版商)”最低求助积分说明 804691